Karachi, Citi Pharma Ltd. reported its financial results with an EPS of Rs. 20.01 for the quarter ending March 2024. The stock’s highest trading rate was Rs. 2,284.61, while the opening rate was at Rs. 24.44. The company, which listed in 2021, declared a 25% bonus despite not distributing dividends this quarter. Citi Pharma maintains a market lot of 1 share.